Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Critical care & anaesthesiaPRM 1794
Dosage formLiquid injectables
Parenteral

Adrenaline 0.01 mg, Lignocaine 20 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1804
Dosage formLiquid injectables
Parenteral

Atracurium Besylate 25 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1805
Dosage formLiquid injectables
Parenteral

Atracurium Besylate 50 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1985
Dosage formDry-powder injectables
Parenteral

Atropine Sulphate

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1806
Dosage formLiquid injectables
Parenteral

Atropine Sulphate 0.5 mg / ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1988
Dosage formDry-powder injectables
Parenteral

Bupivacaine 5 mg

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 50
Critical care & anaesthesiaPRM 1840
Dosage formLiquid injectables
Parenteral

Dextrose 75 mg, Lignocaine 50 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1848
Dosage formLiquid injectables
Parenteral

Dobutamine 250 mg / 5 ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1850
Dosage formLiquid injectables
Parenteral

Dobutamine 50 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 268
Critical care & anaesthesiaPRM 1849
Dosage formLiquid injectables
Parenteral

Dobutamine 50 mg / ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 268
Critical care & anaesthesiaPRM 1865
Dosage formLiquid injectables
Parenteral

Epinephrine, Lidocaine

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 2034
Dosage formDry-powder injectables
Parenteral

Lidocaine 2%

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1906
Dosage formLiquid injectables
Parenteral

Lidocaine 20 mg / ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 4133
Dosage formTablets
Oral

Midazolam 15 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Benzodiazepine sedative
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 4134
Dosage formTablets
Oral

Midazolam 7.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Benzodiazepine sedative
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 5400
Dosage formSyrup
Oral

Midazolam Hcl 2 mg / ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Benzodiazepine sedative
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 1943
Dosage formLiquid injectables
Parenteral

Noradrenaline Bitartrate 4 mg / 2 ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 2049
Dosage formDry-powder injectables
Parenteral

Norepinephrine Bitartrate 2 mg

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 2060
Dosage formDry-powder injectables
Parenteral

Propofol 1%

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 132
Critical care & anaesthesiaPRM 2061
Dosage formDry-powder injectables
Parenteral

Propofol 10 mg

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 238
Critical care & anaesthesiaPRM 1955
Dosage formLiquid injectables
Parenteral

Rocuronium Bromide 50 mg / 5 ml

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 2066
Dosage formDry-powder injectables
Parenteral

Terlipressin

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 274
Critical care & anaesthesiaPRM 1961
Dosage formLiquid injectables
Parenteral

Terlipressin 1 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Critical care & anaesthesiaPRM 2074
Dosage formDry-powder injectables
Parenteral

Vecuronium Bromide

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Critical-care agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 25

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product